What is Amgen's EPS (diluted)?

Amgen (AMGN) reported EPS (diluted) of $3.34 in Q1 2026.

How has Amgen's EPS (diluted) changed year-over-year?

Amgen's EPS (diluted) increased by 4.4% year-over-year, from $3.20 to $3.34.

What is the long-term trend for Amgen's EPS (diluted)?

Over 4 years (2021 to 2025), Amgen's EPS (diluted) has grown at a 8.4% compound annual growth rate (CAGR), from $10.30 to $14.24.

What does EPS (diluted) mean?

Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.

Amgen AMGN EPS (Diluted)

EPS (Diluted) at other companies

Eli LillyLLY

$8.26+170%

PfizerPFE

$0.47-9.6%

Regeneron PharmaceuticalsREGN

$6.75-7.2%

Nektar TherapeuticsNKTR

-$1.82+49.7%

Rigel PharmaceuticalsRIGL

$0.44-30.2%

Jazz PharmaceuticalsJAZZ

$4.43+391%

Other financials

Income statement

See full

Revenue$8.6B+5.8%

Gross profit$5.9B+13.4%

Operating income$2.7B+126%

Net income$1.8B+5.1%

Balance sheet

See full

Cash & equivalents$559.0M+10.0%

Total debt$57.3B-0.1%

Total equity$9.2B+48.1%

Total assets$92.5B+3.5%

Cash flow

See full

Operating cash flow$2.2B+57.4%

CapEx$712.0M+73.2%

Free cash flow$1.5B+50.7%

Valuation

See full

Market cap$190.42B+22.4%

Enterprise value$247.18B+16.4%

P/E24.4×-1.8×

P/S5.1×+0.6×

Profitability

See full

Gross margin68.3%+5.3pp

Operating margin28.4%+6.6pp

Net margin21%+3.6pp

FCF margin23.1%-8.9pp

Returns & leverage

See full

Return on equity101.3%-4.4pp

Debt / equity6.2×-3.0×

Current ratio1.3×+0.1×

Where this comes from

Reported directly by Amgen in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The official record: Amgen’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Amgen's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Amgen's EPS (diluted)?: Amgen (AMGN) reported EPS (diluted) of $3.34 in Q1 2026.
How has Amgen's EPS (diluted) changed year-over-year?: Amgen's EPS (diluted) increased by 4.4% year-over-year, from $3.20 to $3.34.
What is the long-term trend for Amgen's EPS (diluted)?: Over 4 years (2021 to 2025), Amgen's EPS (diluted) has grown at a 8.4% compound annual growth rate (CAGR), from $10.30 to $14.24.
What does EPS (diluted) mean?: Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.